Alpha-1 antitrypsin deficiency (AATD) has turned into the most crowded proving ground in genetic medicine, with five editing companies reporting fresh...

In 2021, we've seen positive clinical data for the first ever in vivo CRISPR medicines, base editors are heading for the clinic, and CRISPR therapies...

CRISPR Therapeutics and ViaCyte announced yesterday that Canada’s medical agency Health Canada has approved their clinical trial application for...